News Articles Tagged: Epigenetic Therapy

Triacetyl-azacytidine: A Key Prodrug for Reversing Epigenetic Changes

Learn about Triacetyl-azacytidine (CAS 10302-78-0), a crucial prodrug for reversing epigenetic alterations. Explore its role in disease treatment and discover why partnering with a reliable supplier is essential for R&D success.

Understanding DNA Methyltransferase Inhibitors for Cancer Therapy

Explore how DNA methyltransferase inhibitors, like Triacetyl-azacytidine, are revolutionizing cancer therapy by reversing epigenetic changes. Learn about their mechanisms and applications from a leading supplier.

Exploring the Efficacy of DOT1L Inhibitors in MLL-Rearranged Leukemia

Delve into the research on DOT1L inhibitors like EPZ-5676 (Pinometostat), focusing on their role in MLL-rearranged leukemia. Find reliable suppliers for these critical research compounds.

The Role of DOT1L Inhibitors in Targeted Cancer Therapy

Explore the therapeutic significance of DOT1L inhibitors like EPZ-5676 (Pinometostat) in modern cancer treatment. Learn about their mechanism, applications, and how to source them from reliable suppliers.

The Role of 2'-Deoxycytidine in Epigenetic Cancer Therapy

Explore how 2'-deoxycytidine influences DNA methylation and gene reactivation, its impact on tumor suppressor genes, and its potential as an epigenetic agent in cancer treatment.

The Role of Azacitidine (CAS 320-67-2) in Epigenetic Cancer Therapies

Discover the significance of Azacitidine (CAS 320-67-2) as a key player in epigenetic cancer therapies, detailing its impact on DNA methylation and gene expression.

Understanding the Azacitidine Mechanism: A Deeper Dive

Explore the intricate mechanism of Azacitidine (CAS 320-67-2), a vital drug in treating MDS and AML, focusing on DNA hypomethylation and its role in cancer therapy.